Home » Topics » BioWorld Science

BioWorld Science
RSS

Silkis licensed to Galderma

April 12, 1996

Teijin reveals new agent for restenosis

April 5, 1996

Generic fluoxetine available in Canada

April 5, 1996

Vivelle U.S. launch

April 5, 1996

Sae Han to distribute erectile dysfunction treatment in Korea

April 5, 1996

HGH delivery agents reported by Emisphere Technologies

April 5, 1996

Lilly claims glucagon-like peptide fragments

April 5, 1996

Jones Medical will market thiamazole in U.S.

April 5, 1996

Provir to enter phase II soon

April 5, 1996

FDA approves lasers for treating BPH

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...